section name header

Evidence summaries

Statins for Age-Related Macular Degeneration

Statins might possibly have no effect on the onset or progression of age-related macular degeneration, although the evidence is insufficient. Level of evidence: "D"

A Cochrane review [Abstract] 1 included 2 studies with a total of 144 subjects. Both trials compared simvastatin versus placebo in older people (older than 50 or 60 years) with high risk of developing AMD (drusen present on examination).

Neither trial reported data for change in visual acuity. Low-quality evidence from the smaller trial, with 30 participants, did not show a statistically significant difference between the simvastatin and placebo groups in visual acuity values at three months of treatment (decimal visual acuity 0.21 ± 0.56 in simvastatin group and 0.19 ± 0.40 in placebo group) or 45 days after the completion of treatment (decimal visual acuity 0.20 ± 0.50 in simvastatin group and 0.19 ± 0.48 in placebo group). The lack of a difference in visual acuity was not explained by lens or retina status, which remained unchanged during and after the treatment period for both groups.Preliminary analyses of 42 participants who had completed 12 months' follow-up in the larger trial did not show a statistically significant difference between simvastatin and the placebo groups for visual acuity, drusen score, or visual function (effect estimates and confidence intervals were not available). Complete data for these outcomes at three years' follow-up were not reported. At three years, low-quality evidence showed an effect of simvastatin in slowing progression of AMD compared with placebo to be uncertain (odds ratio 0.51, 95% confidence interval 0.23 to 1.09).

Comment: The quality of evidence is downgraded by study quality (unclear allocation concealment), by indirectness (short duration of the treatment and follow-up period), and by imprecise results (few patients and wide confidence intervals).

    References

    • Gehlbach P, Li T, Hatef E. Statins for age-related macular degeneration. Cochrane Database Syst Rev 2016;(8):CD006927. [PubMed]

Primary/Secondary Keywords